289 related articles for article (PubMed ID: 19218448)
1. Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation.
Burge S; Teufel DP; Townsley FM; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3142-7. PubMed ID: 19218448
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
3. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
4. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
Teufel DP; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
[TBL] [Abstract][Full Text] [Related]
5. Differences in the transactivation domains of p53 family members: a computational study.
Mavinahalli JN; Madhumalar A; Beuerman RW; Lane DP; Verma C
BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S5. PubMed ID: 20158876
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain.
Nyman U; Vlachos P; Cascante A; Hermanson O; Zhivotovsky B; Joseph B
Mol Cell Biol; 2009 Apr; 29(7):1814-25. PubMed ID: 19158275
[TBL] [Abstract][Full Text] [Related]
7. Conformational stability and activity of p73 require a second helix in the tetramerization domain.
Coutandin D; Löhr F; Niesen FH; Ikeya T; Weber TA; Schäfer B; Zielonka EM; Bullock AN; Yang A; Güntert P; Knapp S; McKeon F; Ou HD; Dötsch V
Cell Death Differ; 2009 Dec; 16(12):1582-9. PubMed ID: 19763140
[TBL] [Abstract][Full Text] [Related]
8. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
Ciribilli Y; Monti P; Bisio A; Nguyen HT; Ethayathulla AS; Ramos A; Foggetti G; Menichini P; Menendez D; Resnick MA; Viadiu H; Fronza G; Inga A
Nucleic Acids Res; 2013 Oct; 41(18):8637-53. PubMed ID: 23892287
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
[TBL] [Abstract][Full Text] [Related]
10. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.
Teufel DP; Bycroft M; Fersht AR
Oncogene; 2009 May; 28(20):2112-8. PubMed ID: 19363523
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
van Dieck J; Brandt T; Teufel DP; Veprintsev DB; Joerger AC; Fersht AR
Oncogene; 2010 Apr; 29(14):2024-35. PubMed ID: 20140014
[TBL] [Abstract][Full Text] [Related]
12. MDM2 suppresses p73 function without promoting p73 degradation.
Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
[TBL] [Abstract][Full Text] [Related]
13. The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.
Patel S; Bui TT; Drake AF; Fraternali F; Nikolova PV
Biochemistry; 2008 Mar; 47(10):3235-44. PubMed ID: 18260640
[TBL] [Abstract][Full Text] [Related]
14. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
Zhang L; Nie L; Maki CG
Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.
Zeng X; Li X; Miller A; Yuan Z; Yuan W; Kwok RP; Goodman R; Lu H
Mol Cell Biol; 2000 Feb; 20(4):1299-310. PubMed ID: 10648616
[TBL] [Abstract][Full Text] [Related]
16. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
[TBL] [Abstract][Full Text] [Related]
17. Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition.
Shin JS; Ha JH; Lee DH; Ryu KS; Bae KH; Park BC; Park SG; Yi GS; Chi SW
Cell Cycle; 2015; 14(4):533-43. PubMed ID: 25591003
[TBL] [Abstract][Full Text] [Related]
18. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of cellular and viral promoters by p73 and p53.
Deb D; Lanyi A; Scian M; Keiger J; Brown DR; Le Roith D; Deb SP; Deb S
Int J Oncol; 2001 Feb; 18(2):401-9. PubMed ID: 11172610
[TBL] [Abstract][Full Text] [Related]
20. Impact of cadmium, cobalt and nickel on sequence-specific DNA binding of p63 and p73 in vitro and in cells.
Adámik M; Bažantová P; Navrátilová L; Polášková A; Pečinka P; Holaňová L; Tichý V; Brázdová M
Biochem Biophys Res Commun; 2015 Jan; 456(1):29-34. PubMed ID: 25446071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
